| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |